The Kaplan-Meier plotter (KM-plot) web-based application [13] was used to assess associations between MEF2D and ZNF100 expression and outcome using data available from serous ovarian cancer patients. This evidence concerns the gene ZNF100 and ovarian serous adenocarcinoma.